Harrow Health Acquires Japan-Approved Ophthalmic Injection For Undisclosed Sum

  • For an undisclosed amount, Harrow Health Inc HROW has agreed to acquire MAQ-100 U.S. and Canadian commercial rights from Wakamoto Pharmaceutical Co Ltd.
  • MAQ-100 is a preservative-free triamcinolone acetonide ophthalmic injection.
  • MAQ-100 is sold by Wakamoto in Japan as MaQaid and is indicated as an intravitreal injection for visualization for vitrectomy. 
  • Since its initial approval, the indication for MaQaid was expanded to include alleviation of diabetic macular edema, macular edema associated with retinal vein occlusion, and non‑infectious uveitis. 
  • Harrow will initially focus on MAQ-100 development for visualization during vitrectomy.
  • Mark L. Baum, CEO of Harrow Health, stated, "this transaction is an excellent strategic fit with our recent commitment to expand our footprint to include retina‑focused surgeons and follows our recent announcement of the acquisition of AMP‑100, a patented, innovative ocular surface anesthetic drug candidate." 
  • Under the terms of the agreement, Wakamoto will receive payments based on the achievement of commercial milestones and supply Harrow with MAQ-100. 
  • Harrow Health will have marketing rights for the U.S. and Canada, while Wakamoto Pharmaceuticals will retain MAQ-100 marketing rights in other countries.
  • Price Action: HROW shares closed 1.36% lower at $8.69 on Tuesday.

Posted In: BriefsBiotechM&ANewsHealth CareGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.